Clinical Trials
11 trialsNCT07597772 2026-05-19
Preliminary Trial of SNA014 for Pancreatic Cancer
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT07033689 2026-04-03
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
SONIRE Therapeutics Inc.
Phase EARLY_PHASE1 Recruiting
NCT06645808 2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1 Recruiting
NCT06828328 2025-12-23
A Study of GC203 TIL in PDCA (RJ)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT06645301 2024-10-16
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06284226 2024-04-16
CCT-ANK-11
Beijing Kejing Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Withdrawn
NCT05465590 2023-12-21
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
Phase EARLY_PHASE1 Withdrawn
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05860374 2023-05-16
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05275062 2022-03-11
Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04123574 2022-02-24
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
BioXcel Therapeutics Inc
Phase EARLY_PHASE1 Withdrawn